The number of new HIV infections in New York is falling to a historically low level

The number of new HIV diagnoses in New York City has fallen below 2000 for the first time since registration in 2001, officials reveal.


Last year 1,917 New Yorkers were diagnosed with HIV, a decrease of 2,157 the year before and one of 4,846 in 2001.

It comes from data showing that the number of people in New York who use PrEP (pre-exposure prophylaxis) is increasing, a drug that reduces a person's risk of HIV by 99 percent.

Although rates have been falling steadily for years, this new report shows a promising fall in rates among women who have not fallen so quickly.

Decreases in new HIV diagnoses were seen in all five boroughs, all races, men and women. There was a difference in age: the percentages dropped among those aged 49 and older, but not so much among younger age groups

Decreases in new HIV diagnoses were seen in all five boroughs, all races, men and women. There was a difference in age: the percentages dropped among those aged 49 and older, but not so much among younger age groups

Dr. Health Commissioner Oxiris Barbot said the record is a testament to the city campaigns that New Yorkers have been trying to teach about ways to have safer sex instead of demonizing sex.


& # 39; We use a data-driven, gender-positive approach to HIV prevention that is firmly based on fairness – and we prove it works & # 39 ;, Barbot said.

& # 39; New York City can put an end to the epidemic if we continue to fight against the stigma, prejudice and discrimination that are still important drivers of HIV, especially among black and latino men who have sex with men. & # 39;

Decreases in new HIV diagnoses were seen in all five boroughs, all races, men and women.

There was an age difference: the rates fell among those aged 49 and older, but not so much among younger age groups.

Dr. Oni Blackstock, assistant commissioner for the HIV department of the health department, said: & # 39; These data demonstrate the power of our dynamic, forward-looking approach to ending the epidemic, and what we can achieve when community and government come together for science give priority over stigma and gender positivity over shame.

& # 39; But there is still work to be done. Until we see fair progress among New Yorkers from all walks of life, we must redouble our efforts to combat institutional racism, sexism, homophobia, transphobia and other forms of stigma that put people at greater risk of HIV infection and, for people with bring HIV, care and treatment out of reach. & # 39;

New York has long been at the forefront of the fight against HIV, with advertising campaigns promoting drugs to prevent HIV and drugs that can make someone's HIV intolerable.


For people who do not have HIV, a drug known as PrEP (pre-exposure prophylaxis) can be used to reduce the risk of HIV by 99 percent (i.e., more effective than the pill in preventing pregnancy).

For those who have HIV, ART (antiretroviral therapy) should be used to suppress the virus. After six months at ART, the virus becomes undetectable and is therefore non-transferable.

This year, New York City commited subway & # 39; s with couples' posters stating that & # 39; HIV cannot be passed on if the virus is undetectable & # 39 ;, to spread the message.

And recently, a report from DOHMH researcher Paul Salcuni revealed prescriptions for pre-exposure prophylaxis (PrEP) – the drug that protects HIV-negative people from contracting the disease – by nearly 1,000 percent in New York City between 2014 and 2016.

"More than 100,000 New Yorkers have died tragically as a result of HIV / AIDS – but in this generation we have the opportunity to end this epidemic once and for all," said Senator Brad Hoylman.


& # 39; It is so exciting to see New York City policies making a difference, with new HIV diagnoses in 2018 at 67 percent since 2001. & # 39;


Before 1996, HIV was a death sentence.

Then ART (antiretroviral therapy) was made, suppressing the virus, meaning that a person can live as long as anyone, despite HIV.

Drugs were also invented to reduce the risk of an HIV-negative person contracting the virus by 99%.

In recent years, research has shown that ART can suppress HIV in such a way that the virus becomes non-transferable for sexual partners.


That has spurred a movement to lower the crime of infecting a person with HIV: it leaves the victim with lifelong, expensive drugs, but it does not mean a certain death.

Here is more about the new life-saving and preventive medicines:

1. Medicines for HIV-positive people

It suppresses their viral load, making the virus non-transferable

Anti-retroviral therapy (ART) was discovered in 1996.


The drug, a triple combination, changed HIV from a fatal diagnosis to a manageable chronic condition.

It suppresses the virus and prevents it from developing into AIDS (Acquired Immunodeficiency Syndrome), as a result of which the body is not resistant to infections.

After religiously taking the daily pill for six months, it suppresses the virus in such a way that it is not detectable.

And once a person's viral load is undetectable, they cannot transfer HIV to anyone else, according to dozens of studies, including a ten-year study by the National Institutes of Health.

Public health institutions around the world now recognize that U = U (non-detectable equivalent to non-transferable).

2. Medicines for HIV negative people

It is 99% effective in preventing HIV

PrEP (prophylaxis before exposure) became available in 2012.

This pill works as & # 39;the pill & # 39; – it is taken daily and is 99 percent effective in preventing HIV infection (more effective than the birth control pill in preventing pregnancy).

It consists of two medicines (tenofovir dosproxil fumarate and emtricitabine). These drugs can trigger a direct attack on any trace of HIV that enters the person's bloodstream before it can spread through the body.


. (tagsToTranslate) dailymail (t) health (t) New York

- Advertisement -